Brain Tumor Centers

Find U.S. facilities with actively recruiting interventional brain-tumor trials. Choose one state at a time; facility details load only after you select a facility.

Back to facilities in Washington

Swedish Medical Center-First Hill

Seattle, Washington 98122

Reported site contacts

Charles W. Drescher — principal investigator
Trial: NCT03418961

Charles W. Drescher — principal investigator
Trial: NCT04511013

Site Public Contact — contact
pcrc-ncorp@swedish.org
206-215-3086
Trial: NCT03418961

Site Public Contact — contact
pcrc-ncorp@swedish.org
206-215-3086
Trial: NCT04511013

Recruiting trials at this facility

• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases (NCT04511013)
  Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8
• S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity (NCT03418961)
  Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7